| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $1.31 ▲ +4.80% | Yesterday | $1.28 ▼ -2.34% | Tomorrow's Actinium Pharmaceuticals Inc. (Delaware) Common Stock (ATNM) setup is anchored to $1.25 and targets $1.31 (+4.80%). The near-term read is upside; watch $1.31 / $1.23 because daily realized volatility is about 5.53%. |
Tomorrow's Actinium Pharmaceuticals Inc. (Delaware) Common Stock (ATNM) setup is anchored to $1.25 and targets $1.31 (+4.80%). The near-term read is upside; watch $1.31 / $1.23 because daily realized volatility is about 5.53%. | ||||
| Week | $1.39 ▲ +11.20% | Last Week | $1.34 ▼ -6.72% | The 7-day Actinium Pharmaceuticals Inc. (Delaware) Common Stock model moves from $1.34 to $1.39 (+11.20%). It gives upside momentum context for this stock, so breaks around $1.31 / $1.23 matter more than a single tick. |
The 7-day Actinium Pharmaceuticals Inc. (Delaware) Common Stock model moves from $1.34 to $1.39 (+11.20%). It gives upside momentum context for this stock, so breaks around $1.31 / $1.23 matter more than a single tick. | ||||
| Month | $1.49 ▲ +19.20% | Last Month | $1.30 ▼ -3.85% | The 1-month Actinium Pharmaceuticals Inc. (Delaware) Common Stock target is $1.49 (+19.20%), compared with the live reference near $1.25. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Actinium Pharmaceuticals Inc. (Delaware) Common Stock target is $1.49 (+19.20%), compared with the live reference near $1.25. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $1.61 ▲ +28.80% | Last Year | $1.67 ▼ -25.15% | The 1-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock scenario points to $1.61 (+28.80%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock scenario points to $1.61 (+28.80%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $1.87 ▲ +49.60% | 5 Years Ago | $7.48 ▼ -83.29% | The 5-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock view is $1.87 (+49.60%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock view is $1.87 (+49.60%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 5.1 | Bearish |
| MACD | 0.11 | Bullish |
| SMA 50 | $1.34 | Mid |
| SMA 200 | $2.06 | Mid |
| EMA 20 | $2.40 | Mid |
| Opening Price | $1.27 | Start Date | 2020-01-02 |
| Day Range | $1.25 – $1.33 | Market Cap | $47.69M |
| Monthly Range | $1.08 – $1.52 | 24h Volume | n/a |
| 90D Range | $0.9804 – $1.52 | Circulating | n/a |
| 52W Range | $0.9804 – $1.94 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.